Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Oronsky

Showing results (71-80 of 115) with videos related to

Pageof 12
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 16, 2012
Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agentJan Scicinski, Bryan Oronsky, Michael Taylor, et al.
Neoplasia (New York, N.Y.)|December 12, 2017
Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A ReviewBryan Oronsky, Patrick Ma, Tony R Reid, et al.
Case Reports in Oncology|July 13, 2016
Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum DoubletsCorey A Carter, Bryan Oronsky, Scott Caroen, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2017
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and managementBryan Oronsky, Scott Caroen, Arnold Oronsky, et al.
Expert Opinion on Investigational Drugs|December 11, 2020
Results from a biomarker study to accompany a phase II trial of RRx-001 with reintroduced platinum-based chemotherapy in relapsed small cell carcinomaMin-Jung Lee, Yusuke Tomita, Akira Yuno, et al.
Oncotarget|December 20, 2017
Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumorsNatarajan Raghunand, Jan Scicinski, Gerald P Guntle, et al.
Bioanalysis|May 9, 2014
Development of methods for the bioanalysis of RRx-001 and metabolitesJan Scicinski, Bryan Oronsky, Vance Cooper, et al.
Case Reports in Oncology|May 18, 2017
Cushing's Syndrome, Cortisol, and Cognitive Competency: A Case ReportNeil Oronsky, Bennett Thilagar, Carolyn M Ray, et al.
Oncotarget|March 24, 2016
Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapiesCorey A Carter, Karen Zeman, Regina M Day, et al.
Clinical Case Reports|December 20, 2018
Complete metabolic response of metastatic castration-resistant neuroendocrine carcinoma of the prostate after treatment with RRx-001 and reintroduced platinum doubletsMichelle Ojemuyiwa, Karen Zeman, Alexander Spira, et al.
Pageof 12

Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 16, 2012
Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agentJan Scicinski, Bryan Oronsky, Michael Taylor, et al.
Neoplasia (New York, N.Y.)|December 12, 2017
Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A ReviewBryan Oronsky, Patrick Ma, Tony R Reid, et al.
Case Reports in Oncology|July 13, 2016
Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum DoubletsCorey A Carter, Bryan Oronsky, Scott Caroen, et al.
Cancer Chemotherapy and Pharmacology|July 22, 2017
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and managementBryan Oronsky, Scott Caroen, Arnold Oronsky, et al.
Expert Opinion on Investigational Drugs|December 11, 2020
Results from a biomarker study to accompany a phase II trial of RRx-001 with reintroduced platinum-based chemotherapy in relapsed small cell carcinomaMin-Jung Lee, Yusuke Tomita, Akira Yuno, et al.
Oncotarget|December 20, 2017
Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumorsNatarajan Raghunand, Jan Scicinski, Gerald P Guntle, et al.
Bioanalysis|May 9, 2014
Development of methods for the bioanalysis of RRx-001 and metabolitesJan Scicinski, Bryan Oronsky, Vance Cooper, et al.
Case Reports in Oncology|May 18, 2017
Cushing's Syndrome, Cortisol, and Cognitive Competency: A Case ReportNeil Oronsky, Bennett Thilagar, Carolyn M Ray, et al.
Oncotarget|March 24, 2016
Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapiesCorey A Carter, Karen Zeman, Regina M Day, et al.
Clinical Case Reports|December 20, 2018
Complete metabolic response of metastatic castration-resistant neuroendocrine carcinoma of the prostate after treatment with RRx-001 and reintroduced platinum doubletsMichelle Ojemuyiwa, Karen Zeman, Alexander Spira, et al.
Pageof 12